Jessica Klusek1, Alexis Ruber2, Jane E Roberts2. 1. a Department of Communication Sciences and Disorders , University of South Carolina , Columbia , SC , USA. 2. b Department of Psychology , University of South Carolina , Columbia , SC , USA.
Abstract
OBJECTIVE: The Fragile X Mental Retardation-1 (FMR1) premutation is a common genetic abnormality, affecting ~1:150 women in the United States. Clinical neuropsychologists are becoming increasingly aware of their role in the clinical management of the FMR1 premutation, which is associated with risk for a range of cognitive, executive, neuromotor, and psychological impairments, including neurodegenerative disease. This study investigated atypical eye contact as a critical neuropsychological phenotype associated with the FMR1 premutation. METHODS: Thirty-eight women with the FMR1 premutation and 27 control women engaged in a 20-min conversational sample with an examiner. Eye contact quality was coded from the videotaped samples by blinded coders. Mixed models tested group differences in eye contact during the beginning and the end of the conversation. Social anxiety and broad autism phenotype (BAP) traits were tested as predictors of eye contact quality across the groups. RESULTS: Women with the FMR1 premutation exhibited significantly reduced eye contact during both the beginning and the end of the social interaction, despite a 'warm-up' effect where eye contact improved by the end of the interaction. Eye contact quality was not associated with social anxiety or BAP traits. CONCLUSIONS: This study supports reduced eye contact as a phenotypic feature of the FMR1 premutation, which presents independent of social anxiety and the BAP. These findings contribute to a growing understanding of the neuropsychological phenotype of the FMR1 premutation, which has public health implications given that >1 million individuals in the United States carry this genetic abnormality.
OBJECTIVE: The Fragile X Mental Retardation-1 (FMR1) premutation is a common genetic abnormality, affecting ~1:150 women in the United States. Clinical neuropsychologists are becoming increasingly aware of their role in the clinical management of the FMR1 premutation, which is associated with risk for a range of cognitive, executive, neuromotor, and psychological impairments, including neurodegenerative disease. This study investigated atypical eye contact as a critical neuropsychological phenotype associated with the FMR1 premutation. METHODS: Thirty-eight women with the FMR1 premutation and 27 control women engaged in a 20-min conversational sample with an examiner. Eye contact quality was coded from the videotaped samples by blinded coders. Mixed models tested group differences in eye contact during the beginning and the end of the conversation. Social anxiety and broad autism phenotype (BAP) traits were tested as predictors of eye contact quality across the groups. RESULTS:Women with the FMR1 premutation exhibited significantly reduced eye contact during both the beginning and the end of the social interaction, despite a 'warm-up' effect where eye contact improved by the end of the interaction. Eye contact quality was not associated with social anxiety or BAP traits. CONCLUSIONS: This study supports reduced eye contact as a phenotypic feature of the FMR1 premutation, which presents independent of social anxiety and the BAP. These findings contribute to a growing understanding of the neuropsychological phenotype of the FMR1 premutation, which has public health implications given that >1 million individuals in the United States carry this genetic abnormality.
Entities:
Keywords:
Fragile X premutation; eye gaze; fragile X carriers; social gaze; social phobia
Authors: A Schneider; C Johnston; F Tassone; S Sansone; R J Hagerman; E Ferrer; S M Rivera; D Hessl Journal: Clin Neuropsychol Date: 2016-06-29 Impact factor: 3.535
Authors: Sarah L Nolin; W Ted Brown; Anne Glicksman; George E Houck; Alice D Gargano; Amy Sullivan; Valérie Biancalana; Karen Bröndum-Nielsen; Helle Hjalgrim; Elke Holinski-Feder; Frank Kooy; John Longshore; James Macpherson; Jean-Louis Mandel; Gert Matthijs; Francois Rousseau; Peter Steinbach; Marja-Leena Väisänen; Harriet von Koskull; Stephanie L Sherman Journal: Am J Hum Genet Date: 2003-01-14 Impact factor: 11.025
Authors: A Maddalena; C S Richards; M J McGinniss; A Brothman; R J Desnick; R E Grier; B Hirsch; P Jacky; G A McDowell; B Popovich; M Watson; D J Wolff Journal: Genet Med Date: 2001 May-Jun Impact factor: 8.822
Authors: Deborah A Hall; Rachael C Birch; Mathieu Anheim; Aia E Jønch; Elizabeth Pintado; Joanne O'Keefe; Julian N Trollor; Glenn T Stebbins; Randi J Hagerman; Stanley Fahn; Elizabeth Berry-Kravis; Maureen A Leehey Journal: J Neurodev Disord Date: 2014-07-30 Impact factor: 4.025
Authors: Jessica Klusek; Anna Porter; Leonard Abbeduto; Tatyana Adayev; Flora Tassone; Marsha R Mailick; Anne Glicksman; Bridgette L Tonnsen; Jane E Roberts Journal: Front Genet Date: 2018-08-24 Impact factor: 4.599
Authors: Lauren M Schmitt; Kelli C Dominick; Rui Liu; Ernest V Pedapati; Lauren E Ethridge; Elizabeth Smith; John A Sweeney; Craig A Erickson Journal: Front Integr Neurosci Date: 2022-01-03